MX2008011978A - Tratamiento del cancer de seno negativo al triple receptor. - Google Patents
Tratamiento del cancer de seno negativo al triple receptor.Info
- Publication number
- MX2008011978A MX2008011978A MX2008011978A MX2008011978A MX2008011978A MX 2008011978 A MX2008011978 A MX 2008011978A MX 2008011978 A MX2008011978 A MX 2008011978A MX 2008011978 A MX2008011978 A MX 2008011978A MX 2008011978 A MX2008011978 A MX 2008011978A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- breast cancer
- receptor negative
- negative breast
- triple receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere al uso de una preparación de liposomas para la preparación de una composición farmacéutica y el uso de esa composición para el tratamiento de cáncer de seno "negativo al triple receptor.".
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06005893 | 2006-03-22 | ||
PCT/EP2007/002352 WO2007107305A2 (en) | 2006-03-22 | 2007-03-16 | Treatment of triple receptor negative breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008011978A true MX2008011978A (es) | 2009-04-22 |
Family
ID=38421534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008011978A MX2008011978A (es) | 2006-03-22 | 2007-03-16 | Tratamiento del cancer de seno negativo al triple receptor. |
Country Status (10)
Country | Link |
---|---|
US (4) | US8168216B2 (es) |
EP (2) | EP3056196A1 (es) |
AU (1) | AU2007228984B2 (es) |
BR (1) | BRPI0709075A2 (es) |
CA (2) | CA2922029C (es) |
ES (1) | ES2609388T3 (es) |
MX (1) | MX2008011978A (es) |
RU (1) | RU2448697C2 (es) |
WO (1) | WO2007107305A2 (es) |
ZA (1) | ZA200808953B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101764375B1 (ko) | 2005-02-18 | 2017-08-03 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 조합 및 투여 방식, 및 조합 요법 |
AU2006243337B2 (en) | 2005-05-04 | 2011-09-29 | Syncore Biotechnology Co., Ltd | Method of administering a cationic liposomal preparation comprising paclitaxel |
KR20080035630A (ko) | 2005-07-18 | 2008-04-23 | 바이파 사이언스 인코포레이티드 | 암의 치료 |
AU2007228984B2 (en) | 2006-03-22 | 2012-05-03 | Syncore Biotechnology Co., Ltd | Treatment of triple receptor negative breast cancer |
CN101522609A (zh) | 2006-09-05 | 2009-09-02 | 彼帕科学公司 | 癌症的治疗 |
CN102379884A (zh) | 2006-09-05 | 2012-03-21 | 彼帕科学公司 | Parp抑制剂对脂肪酸合成的抑制及其治疗方法 |
CN101917982B (zh) | 2007-11-12 | 2013-03-20 | 彼帕科学公司 | 使用4-碘-3-硝基苯甲酰胺与抗肿瘤剂组合治疗乳腺癌 |
CN107158389A (zh) | 2010-03-29 | 2017-09-15 | 阿布拉科斯生物科学有限公司 | 增强药物递送和治疗剂有效性的方法 |
JP5926724B2 (ja) | 2010-03-29 | 2016-05-25 | アブラクシス バイオサイエンス, エルエルシー | がんを処置する方法 |
EP2394640A1 (en) | 2010-05-21 | 2011-12-14 | MediGene AG | Improved liposomal formulations of lipophilic compounds |
JP6257324B2 (ja) | 2010-06-04 | 2018-01-10 | アブラクシス バイオサイエンス, エルエルシー | 膵臓がんの処置方法 |
SG10201608469RA (en) | 2012-05-16 | 2016-11-29 | Novartis Ag | Dosage regimen for a pi-3 kinase inhibitor |
US9801844B2 (en) * | 2012-05-24 | 2017-10-31 | The Research Foundation Of The City University Of New York | Methods and compositions for the treatment of cancer |
US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
PT2872482T (pt) * | 2012-07-13 | 2020-09-22 | Oncternal Therapeutics Inc | Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm) |
AU2013353745A1 (en) * | 2012-12-04 | 2015-06-11 | Eisai R&D Management Co., Ltd. | Use of eribulin in the treatment of breast cancer |
TWI760319B (zh) * | 2015-12-30 | 2022-04-11 | 杏國新藥股份有限公司 | 乳癌治療 |
TWI852903B (zh) * | 2017-01-05 | 2024-08-21 | 杏國新藥股份有限公司 | 胰臟癌治療 |
US10729650B2 (en) * | 2017-01-23 | 2020-08-04 | United States Of America As Represented By The Secretary Of The Air Force | Skin punch biopsy and wound-debridgement training model |
US11260132B2 (en) | 2017-03-16 | 2022-03-01 | Children's Medical Center Corporation | Engineered liposomes as cancer-targeted therapeutics |
TW202337497A (zh) | 2022-02-18 | 2023-10-01 | 中國大陸商重慶明道浩悅生物科技有限公司 | 鼻內調配物及抗sars-cov-2棘蛋白抗體 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW197439B (es) | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
WO1993010076A1 (en) | 1991-11-22 | 1993-05-27 | The University Of Mississippi | Synthesis and optical resolution of the taxol side chain and related compounds |
IT1254135B (it) | 1992-01-16 | 1995-09-08 | Sigma Tau Ind Farmaceuti | Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica. |
US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
EP0706373B1 (en) | 1992-03-23 | 2000-07-19 | Georgetown University | Liposome encapsulated taxol and a method of using the same |
WO1993023555A1 (en) | 1992-05-21 | 1993-11-25 | The Penn State Research Foundation | Cultured taxus tissues as a source of taxol, related taxanes and other novel anti-tumor/anti-viral compounds |
US5274137A (en) | 1992-06-23 | 1993-12-28 | Nicolaou K C | Intermediates for preparation of taxols |
US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
CA2086874E (en) | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
US5202448A (en) | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
FR2696464B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
FR2696458B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
FR2696461B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
FR2696462B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
FR2696463B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
US5279949A (en) | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
US5415869A (en) * | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
DE4447770C2 (de) | 1994-08-20 | 2002-12-19 | Max Delbrueck Centrum | Verfahren zur Herstellung von liposomal verkapseltem Taxol |
US5834012A (en) * | 1995-05-03 | 1998-11-10 | Roman Perez-Soler | Lipid complexed topoisomerase I inhibitors |
US5821263A (en) | 1996-08-26 | 1998-10-13 | Bristol-Myers Squibb Company | Sulfenamide taxane derivatives |
WO1998022451A1 (fr) | 1996-11-19 | 1998-05-28 | Daiichi Pharmaceutical Co., Ltd. | Derives taxol |
US5977386A (en) | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
US20030087954A1 (en) | 1997-01-07 | 2003-05-08 | Sonus Pharmaceuticals, Inc. | Method of treating bladder carcinoma using a Taxane/Tocopherol formulation |
US5837283A (en) | 1997-03-12 | 1998-11-17 | The Regents Of The University Of California | Cationic lipid compositions targeting angiogenic endothelial cells |
US7112338B2 (en) * | 1997-03-12 | 2006-09-26 | The Regents Of The University Of California | Cationic liposome delivery of taxanes to angiogenic blood vessels |
US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
JPH1192468A (ja) | 1997-09-17 | 1999-04-06 | Yakult Honsha Co Ltd | 新規なタキサン誘導体 |
JP4153660B2 (ja) | 1997-10-08 | 2008-09-24 | 株式会社横浜国際バイオ研究所 | タキソイド誘導体およびその製造方法 |
US6214821B1 (en) * | 1998-03-05 | 2001-04-10 | Washington State University Research Foundation | Methods and composition for the inhibition of cancer cells |
US7314637B1 (en) | 1999-06-29 | 2008-01-01 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6146659A (en) | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
CA2383412C (en) | 1999-09-09 | 2010-02-02 | The Regents Of The University Of California | Cationic liposome delivery of taxanes to angiogenic blood vessels |
US20020041888A1 (en) | 2000-04-10 | 2002-04-11 | Moshe Flashner-Barak | Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
EP1278512A2 (en) | 2000-05-03 | 2003-01-29 | MBT Munich Biotechnology AG | Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
US6569853B1 (en) | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
UY27185A1 (es) | 2001-02-28 | 2002-09-30 | Bristol Myers Squibb Co | Dosificación metronómica de taxanos |
US20030008014A1 (en) | 2001-06-20 | 2003-01-09 | Shelness Gregory S. | Truncated apolipoprotein B-containing lipoprotein particles for delivery of compounds to tissues or cells |
WO2003022248A1 (en) | 2001-09-13 | 2003-03-20 | Korea Institute Of Science And Technology | Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
AU2002334939A1 (en) * | 2001-10-12 | 2003-04-22 | Eugene R. Cooper | Compositions having a combination of particles for immediate release and for controlled release |
US6627614B1 (en) * | 2002-06-05 | 2003-09-30 | Super Gen, Inc. | Sequential therapy comprising a 20(S)-camptothecin and an anthracycline |
DE60329497D1 (de) | 2002-06-26 | 2009-11-12 | Medigene Ag | Herstellung einer kationisch liposomalen zubereitung, einen lipophilen wirkstoff enthaltend |
DE60335279D1 (de) | 2002-06-26 | 2011-01-20 | Medigene Ag | Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem |
US20040076582A1 (en) | 2002-08-30 | 2004-04-22 | Dimatteo Kristian | Agent delivery particle |
EP1651035A2 (en) * | 2003-07-31 | 2006-05-03 | 3M Innovative Properties Company | Compositions for encapsulation and controlled release |
PT2286794T (pt) | 2003-10-15 | 2016-07-13 | Syncore Biotechnology Co Ltd | Uso de lipossomas catiónicos contendo placlitaxel |
US7405237B2 (en) | 2004-07-28 | 2008-07-29 | Celgene Corporation | Isoindoline compounds and methods of their use |
US7563570B2 (en) | 2004-10-29 | 2009-07-21 | Pangaea Biotech | Method of determining a chemotherapeutic regimen for non small cell lung cancer based on BRCA1 expression |
AU2006243337B2 (en) * | 2005-05-04 | 2011-09-29 | Syncore Biotechnology Co., Ltd | Method of administering a cationic liposomal preparation comprising paclitaxel |
AU2007228984B2 (en) * | 2006-03-22 | 2012-05-03 | Syncore Biotechnology Co., Ltd | Treatment of triple receptor negative breast cancer |
EP2073823A1 (en) * | 2006-10-13 | 2009-07-01 | Medigene AG | Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer |
-
2007
- 2007-03-16 AU AU2007228984A patent/AU2007228984B2/en not_active Ceased
- 2007-03-16 EP EP16158395.0A patent/EP3056196A1/en not_active Withdrawn
- 2007-03-16 RU RU2008141763/15A patent/RU2448697C2/ru active
- 2007-03-16 MX MX2008011978A patent/MX2008011978A/es active IP Right Grant
- 2007-03-16 US US12/293,039 patent/US8168216B2/en not_active Expired - Fee Related
- 2007-03-16 CA CA2922029A patent/CA2922029C/en active Active
- 2007-03-16 CA CA2646156A patent/CA2646156C/en active Active
- 2007-03-16 ES ES07723330.2T patent/ES2609388T3/es active Active
- 2007-03-16 WO PCT/EP2007/002352 patent/WO2007107305A2/en active Application Filing
- 2007-03-16 BR BRPI0709075-7A patent/BRPI0709075A2/pt not_active Application Discontinuation
- 2007-03-16 EP EP07723330.2A patent/EP2010151B8/en not_active Not-in-force
-
2008
- 2008-10-20 ZA ZA200808953A patent/ZA200808953B/xx unknown
-
2012
- 2012-03-26 US US13/430,393 patent/US9144563B2/en not_active Expired - Fee Related
-
2015
- 2015-08-24 US US14/833,442 patent/US9707204B2/en active Active
-
2017
- 2017-06-12 US US15/620,078 patent/US20170273934A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2010151B1 (en) | 2016-10-12 |
CA2922029A1 (en) | 2007-09-27 |
US20120183604A1 (en) | 2012-07-19 |
WO2007107305A2 (en) | 2007-09-27 |
US20150359778A1 (en) | 2015-12-17 |
BRPI0709075A2 (pt) | 2011-10-11 |
US8168216B2 (en) | 2012-05-01 |
US20090186078A1 (en) | 2009-07-23 |
EP2010151A2 (en) | 2009-01-07 |
ES2609388T3 (es) | 2017-04-20 |
ZA200808953B (en) | 2009-06-24 |
CA2646156C (en) | 2016-05-24 |
RU2448697C2 (ru) | 2012-04-27 |
US20170273934A1 (en) | 2017-09-28 |
CA2646156A1 (en) | 2007-09-27 |
CA2922029C (en) | 2017-11-28 |
EP3056196A1 (en) | 2016-08-17 |
EP2010151B8 (en) | 2017-01-11 |
RU2008141763A (ru) | 2010-04-27 |
AU2007228984A1 (en) | 2007-09-27 |
US9707204B2 (en) | 2017-07-18 |
US9144563B2 (en) | 2015-09-29 |
WO2007107305A3 (en) | 2007-11-01 |
AU2007228984B2 (en) | 2012-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008011978A (es) | Tratamiento del cancer de seno negativo al triple receptor. | |
EP2400847A4 (en) | SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOIN COMPOUNDS | |
IL184872A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
IL185063A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
MY179527A (en) | Catecholamine derivatives useful for the treatment of parkinson's disease | |
MX2010014234A (es) | Compuestos pirazol 436. | |
MX2007010996A (es) | Nuevas composiciones de liposomas. | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
IN2014MN00139A (es) | ||
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
UA96785C2 (uk) | Заміщені похідні оксиндолу та їх застосування як лігандів рецептора вазопресину | |
UA96449C2 (en) | Stable laquinimod preparations | |
MY156288A (en) | Pharmaceutical formulations containing dopamine receptor ligands. | |
MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
DK2018170T3 (da) | Lægemiddel mod brystcancer | |
MX2010006204A (es) | Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
MX2009007864A (es) | Derivados de 6-oxo-6,7-dihidro-5h-dibenzo[b,d]azepin-7-ilo. | |
MY156302A (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES | |
IL196606A (en) | Use of Eskin for the preparation of medical preparations and medical preparations containing Eskin for the treatment of diseases | |
PL1809288T3 (pl) | Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych | |
UA104281C2 (ru) | Противоопухолевые аналоги пептидов, способ их получения и фармацевтическая композиция на них основе | |
DE602007007934D1 (en) | Imidazoazephinonverbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |